- Home
- ADPT vs IQ Comparison
ADPT vs IQ Comparison
Compare ADPT & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADPT | IQ |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ADPT | IQ |
|---|---|---|
| Price | $15.41 | $1.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $16.60 | $2.87 |
| AVG Volume (30 Days) | 3.0M | ★ 13.8M |
| Earning Date | 11-05-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $252,754,000.00 | ★ $3,808,085,043.00 |
| Revenue This Year | $50.81 | N/A |
| Revenue Next Year | $1.17 | $2.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.57 | N/A |
| 52 Week Low | $5.81 | $1.50 |
| 52 Week High | $20.76 | $2.84 |
Technical Indicators
Market Signals| Indicator | ADPT | IQ |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 36.84 |
| Support Level | $14.58 | $1.97 |
| Resistance Level | $16.26 | $2.08 |
| Average True Range (ATR) | 1.13 | 0.08 |
| MACD | -0.36 | -0.01 |
| Stochastic Oscillator | 13.75 | 7.58 |
Price Performance
Historical ComparisonAbout ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.